May 7, 2018—NovoPath announced that the University of Texas Health Science Center at Houston has selected the NovoPath anatomic pathology software platform as its LIS for the Department of Pathology and Laboratory Medicine.
“Pathology programs are data intensive and a large volume of records must be managed securely. With the new generation of software platforms such as NovoPath, health care providers can customize this information to meet their particular needs and support future growth,” Robert Hunter, MD, PhD, chair, Department of Pathology and Laboratory Medicine, and distinguished chair in molecular pathology, UTHealth, said in a release from NovoPath.
“We are pleased that UTHealth chose NovoPath for its AP platform as it continues to grow and expand its services,” Rick Callahan, vice president of sales and marketing, NovoPath, said in the release. “The UTHealth team did a very thorough evaluation of its needs and followed a rigorous vendor selection process. We are proud that UTHealth selected NovoPath.”